UNSPSC 51373416: Brompheniramine/codeine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373416 Brompheniramine/codeine/phenylephrine is a Commodity code that does not align with recent state and local procurement activity posted under this classification. The two recorded opportunities—one for naloxone and drug deactivation systems (Seminole County, Florida, IFB) and one for generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance, RFP)—fall outside the specific pharmaceutical combination this code nominally describes. State and local government purchasing under this code shows little relevant recent activity, with the posted solicitations reflecting broader drug procurement categories rather than the brompheniramine/codeine/phenylephrine formulation itself.

The mismatch between the code's narrow drug-combination scope and the actual solicitations posted suggests that state and local procurement systems may apply this Commodity code inconsistently or that demand for this specific pharmaceutical formulation remains low enough that current contracting activity does not surface under it. Firms evaluating this code should verify whether their target customers tag related pharmaceutical opportunities (particularly respiratory or cold/cough remedies and opioid-containing products) under this Commodity number or route them through broader generic pharmaceutical family codes instead.